新产业(300832) - 2025 Q3 - 季度财报

Financial Performance - The company's operating revenue for the third quarter reached ¥1,242,791,090.19, an increase of 3.28% compared to the same period last year[4] - Net profit attributable to shareholders decreased by 9.72% to ¥433,730,087.18, while the net profit after deducting non-recurring gains and losses fell by 11.58% to ¥409,788,818.09[4] - The weighted average return on equity decreased by 1.00 percentage points to 5.09% for the current period[4] - Total profit for the same period was CNY 136,664.73 million, a decrease of 13.72% compared to the previous year[21] - The net profit attributable to shareholders was CNY 120,480.26 million, down 12.92% year-on-year[21] - Net profit for the period was ¥1,204,802,622.37, down from ¥1,383,591,276.93, reflecting a decrease of approximately 12.91%[27] - The total comprehensive income for the period was ¥1,189,659,562.61, down from ¥1,360,509,568.22, indicating a decrease of approximately 12.53%[28] Assets and Liabilities - Total assets at the end of the reporting period were ¥9,576,812,383.78, a decrease of 0.44% from the end of the previous year[4] - The total assets of the company at the end of the reporting period were CNY 9,576,812,383.78, slightly down from CNY 9,619,453,527.11 at the beginning of the period[23] - Total liabilities decreased to ¥831,979,766.76 from ¥1,042,846,052.20, a reduction of approximately 20.19%[25] - The company's inventory decreased from CNY 1,197,993,634.12 to CNY 1,000,350,449.40 during the reporting period[23] - The company's long-term receivables increased from CNY 310,795,908.91 to CNY 371,592,090.89[23] Cash Flow - The net cash flow from investment activities was ¥341,719,201.50, a substantial improvement compared to a negative cash flow of ¥653,576,032.58 in the previous period[14] - Cash inflow from operating activities was ¥3,486,671,866.92, compared to ¥3,193,149,417.18 in the previous period, showing an increase of about 9.19%[29] - The net cash flow from operating activities was $1,064,210,655.47, an increase of 11.1% compared to $958,084,817.39 in the previous period[30] - Cash outflow from operating activities totaled $2,422,461,211.45, up from $2,235,064,599.79, reflecting a 8.4% increase[30] - Cash inflow from investing activities decreased to $2,286,755,956.70 from $5,444,209,003.00, a decline of 58.0%[30] - Cash outflow from investing activities was $1,945,036,755.20, down from $6,097,785,035.58, indicating a reduction of 68.1%[30] - Cash flow from financing activities resulted in a net outflow of $1,024,016,805.42, compared to a net outflow of $789,403,367.02 in the previous period[30] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,116[15] - The basic earnings per share decreased to ¥1.5334 from ¥1.7609, a decline of about 12.87%[28] Government Support and Investments - The company received government subsidies amounting to ¥25,582,995.61, reflecting a 109.92% increase compared to the previous year[12] - The company’s investment in construction projects increased by 30.88% to ¥542,567,931.16, indicating ongoing expansion efforts[9] Market Performance - Domestic market main business revenue decreased by 10.95%, while overseas market main business revenue increased by 21.07%[21] - Sales of the MAGLUMI X8 high-speed chemiluminescence immunoassay analyzer reached 4,545 units, solidifying the company's leading position in the high-end chemiluminescence field[21] - The SATLARS T8 fully automated laboratory automation line was successfully launched in June 2024, with a total of 245 units sold globally by the end of the reporting period[21]